Market Overview:
The global amino acid metabolism disorders treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of amino acid metabolism disorders, rising awareness about these disorders, and technological advancements in the field of diagnostics and therapeutics. The global amino acid metabolism disorders treatment market is segmented by type, application, and region. By type, the market is divided into arginine, folic acid, vitamin B6 & B12, thiamine, vitamin D3 & D2 betaine), carlumic acid sapropterin dihydrochloride), and others). Geographically,, the Amino Acid Metabolism Disorders Treatment Market covers North America,, Latin America,, Europe,, Asia Pacific.,and Middle East Africa regions. Some of the key players operating in this market are Akorn Pharmaceuticals Inc., Aegerion Pharmaceuticals Inc., Amgen Inc., BioMarin PharmaceuticalsInc.
Product Definition:
Amino acid metabolism disorders are a group of rare inherited conditions that affect the way the body breaks down amino acids. These conditions can lead to a build-up of toxic levels of amino acids in the blood and other tissues. Amino acid metabolism disorders treatment involves managing symptoms and preventing serious health problems.
Arginine:
Arginine is an amino acid that is derived from the protein of animal and plant origin. It has several medical uses such as treatment of cardiovascular diseases, urinary tract infections, asthma, etc. The most common sources for arginine production include bovine and porcine species.
Folic Acid:
Folic acid is a form of vitamin B9 which is used in the treatment and prevention of several amino acid metabolism disorders. It helps in the production of red blood cells, DNA, and RNA. The most common symptoms associated with lack of folic acid include anemia, weakness, & fatigue. Folate consumption helps to prevent neural tube defects (NTDs) such as spina bifida or other birth defects in infants born prematurely.
Application Insights:
Phenylketonuria (PKU) held the largest share of over 9.0% in 2017 due to its high prevalence and wide treatment acceptance. Phenylalanine is the essential amino acid in humans; however, it can be converted into phenyalanine which is a toxic substance for the brain in case of an overdose. The former one accounts for around 85% cases globally while latter 15%. Treatment includes dietary management along with medication such as argininosuccinic acid, pyridoxamine, ornithine transaminase inhibitor tablets & supplements, etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of patients suffering from amino acid disorders, increasing awareness about these conditions, and availability of effective treatment methods in this region. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as India and China. Moreover, government initiatives for creating awareness about these diseases are also anticipated to propel market growth during the forecast period. For instance, BAYADA Home Health Care provides 24-hour medical services at an affordable cost through home health visits by registered nurses or licensed practical nurses who provide medication instructions and help with activities of daily living along with family members or caregivers (physicians). These services are free under Medicare Part A & B for patients 18 years & older who have been diagnosed with phenylketonuria (PKU)or maple syrup urine disease (MSUD).
Growth Factors:
- Increasing prevalence of amino acid metabolism disorders
- Growing awareness about the available treatments for amino acid metabolism disorders
- Rising demand for better and more effective treatments for amino acid metabolism disorders
- Technological advancements in the field of diagnostics and treatment of amino acid metabolism disorders 5. Availability of government funding and private sector investment for research on new therapies for treating amino acid metabolism disorders
Scope Of The Report
Report Attributes
Report Details
Report Title
Amino Acid Metabolism Disorders Treatment Market Research Report
By Type
Arginine, Folic Acid, Vitamin B6 & B12, Thiamine, Vitamin D, Betaine, Carglumic Acid, Sapropterin Dihydrochloride, Others
By Application
Phenylketonuria, Maple Syrup Urine Disease, Argininosuccinic Acidemia, Citrullinemia, Homocystinuria
By Companies
GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, Koninklijke, Sanofi, Shine Star (Hubei) Biological Engineering, Kyowa Hakko Kirin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Amino Acid Metabolism Disorders Treatment Market Report Segments:
The global Amino Acid Metabolism Disorders Treatment market is segmented on the basis of:
Types
Arginine, Folic Acid, Vitamin B6 & B12, Thiamine, Vitamin D, Betaine, Carglumic Acid, Sapropterin Dihydrochloride, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Phenylketonuria, Maple Syrup Urine Disease, Argininosuccinic Acidemia, Citrullinemia, Homocystinuria
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Pfizer
- AMINO
- Merck
- Recordati
- Koninklijke
- Sanofi
- Shine Star (Hubei) Biological Engineering
- Kyowa Hakko Kirin
Highlights of The Amino Acid Metabolism Disorders Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Arginine
- Folic Acid
- Vitamin B6 & B12
- Thiamine
- Vitamin D
- Betaine
- Carglumic Acid
- Sapropterin Dihydrochloride
- Others
- By Application:
- Phenylketonuria
- Maple Syrup Urine Disease
- Argininosuccinic Acidemia
- Citrullinemia
- Homocystinuria
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amino Acid Metabolism Disorders Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for amino acid metabolism disorders will vary depending on the individual's symptoms and medical history. However, some common treatments include dietary adjustments, supplements of specific amino acids, and medication therapy.
Some of the major players in the amino acid metabolism disorders treatment market are GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, Koninklijke, Sanofi, Shine Star (Hubei) Biological Engineering, Kyowa Hakko Kirin.
The amino acid metabolism disorders treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amino Acid Metabolism Disorders Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amino Acid Metabolism Disorders Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amino Acid Metabolism Disorders Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amino Acid Metabolism Disorders Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amino Acid Metabolism Disorders Treatment Market Size & Forecast, 2020-2028
4.5.1 Amino Acid Metabolism Disorders Treatment Market Size and Y-o-Y Growth
4.5.2 Amino Acid Metabolism Disorders Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Arginine
5.2.2 Folic Acid
5.2.3 Vitamin B6 & B12
5.2.4 Thiamine
5.2.5 Vitamin D
5.2.6 Betaine
5.2.7 Carglumic Acid
5.2.8 Sapropterin Dihydrochloride
5.2.9 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Phenylketonuria
6.2.2 Maple Syrup Urine Disease
6.2.3 Argininosuccinic Acidemia
6.2.4 Citrullinemia
6.2.5 Homocystinuria
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amino Acid Metabolism Disorders Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Arginine
9.6.2 Folic Acid
9.6.3 Vitamin B6 & B12
9.6.4 Thiamine
9.6.5 Vitamin D
9.6.6 Betaine
9.6.7 Carglumic Acid
9.6.8 Sapropterin Dihydrochloride
9.6.9 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Phenylketonuria
9.10.2 Maple Syrup Urine Disease
9.10.3 Argininosuccinic Acidemia
9.10.4 Citrullinemia
9.10.5 Homocystinuria
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Arginine
10.6.2 Folic Acid
10.6.3 Vitamin B6 & B12
10.6.4 Thiamine
10.6.5 Vitamin D
10.6.6 Betaine
10.6.7 Carglumic Acid
10.6.8 Sapropterin Dihydrochloride
10.6.9 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Phenylketonuria
10.10.2 Maple Syrup Urine Disease
10.10.3 Argininosuccinic Acidemia
10.10.4 Citrullinemia
10.10.5 Homocystinuria
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Arginine
11.6.2 Folic Acid
11.6.3 Vitamin B6 & B12
11.6.4 Thiamine
11.6.5 Vitamin D
11.6.6 Betaine
11.6.7 Carglumic Acid
11.6.8 Sapropterin Dihydrochloride
11.6.9 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Phenylketonuria
11.10.2 Maple Syrup Urine Disease
11.10.3 Argininosuccinic Acidemia
11.10.4 Citrullinemia
11.10.5 Homocystinuria
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Arginine
12.6.2 Folic Acid
12.6.3 Vitamin B6 & B12
12.6.4 Thiamine
12.6.5 Vitamin D
12.6.6 Betaine
12.6.7 Carglumic Acid
12.6.8 Sapropterin Dihydrochloride
12.6.9 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Phenylketonuria
12.10.2 Maple Syrup Urine Disease
12.10.3 Argininosuccinic Acidemia
12.10.4 Citrullinemia
12.10.5 Homocystinuria
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Arginine
13.6.2 Folic Acid
13.6.3 Vitamin B6 & B12
13.6.4 Thiamine
13.6.5 Vitamin D
13.6.6 Betaine
13.6.7 Carglumic Acid
13.6.8 Sapropterin Dihydrochloride
13.6.9 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Phenylketonuria
13.10.2 Maple Syrup Urine Disease
13.10.3 Argininosuccinic Acidemia
13.10.4 Citrullinemia
13.10.5 Homocystinuria
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amino Acid Metabolism Disorders Treatment Market: Competitive Dashboard
14.2 Global Amino Acid Metabolism Disorders Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Pfizer
14.3.3 AMINO
14.3.4 Merck
14.3.5 Recordati
14.3.6 Koninklijke
14.3.7 Sanofi
14.3.8 Shine Star (Hubei) Biological Engineering
14.3.9 Kyowa Hakko Kirin
